Latest Superannuation News

Challenger Limited reported a 19% jump in Life sales to $1.7 billion in Q3 FY26, driven by strong annuity demand and offshore growth. Despite a 10% dip in Funds Management FUM amid market volatility, the company advanced key retirement partnerships and tightened its FY26 EPS guidance.

Insignia Financial’s $3.3 billion acquisition by CC Capital Partners has cleared its final legal hurdle, with the Federal Court approving the scheme of arrangement and share trading set to suspend imminently. Shareholders on record will receive $4.80 per share when the deal completes later this month.

The Federal Court has approved the acquisition scheme for Insignia Financial by CC Capital Partners, setting the stage for a $4.80 per share cash payout and imminent ASX suspension.

AMP Limited's first quarter of 2026 saw Platforms net cashflows jump 45% to $1.1 billion, alongside improved outflows in Superannuation & Investments and a $150 million share buyback commencement. The bank's GO deposits also surged, signaling momentum despite market headwinds.

Australian Ethical’s funds under management slid 3.7% to $13.57 billion in Q3 2026 amid market volatility, but the firm bolstered growth with a new $125 million private markets fund backed by the Clean Energy Finance Corporation and solid middle market client wins.

Noxopharm appoints its Chief Scientific Officer Dr Olivier Laczka as CEO, aiming to capitalise on recent clinical successes and expand the Sofra™ technology’s reach in autoimmune and oncology markets.

Insignia Financial shareholders met on 13 April 2026 and overwhelmingly backed a $4.80 per share acquisition scheme by CC Capital, valuing the company at about $3.3 billion and offering a near 57% premium to pre-offer prices.

The GPT Group delivered solid financial and operational results for 2025, growing assets under management to nearly $40 billion and advancing strategic partnerships across retail, logistics, and office sectors.

DroneShield Limited has appointed Angus Bean as its new CEO and Hamish McLennan as Chairman, following the departures of Oleg Vornik and Peter James. The company also reported record cash receipts of $77 million in the first quarter of 2026, reflecting strong growth momentum.

BNK Banking Corporation announces the planned departure of CEO Allan Savins, with CFO Steve Kinsella stepping in as interim CEO from April 2026. The leadership transition marks a pivotal moment for the bank amid its ongoing growth and turnaround.

Vitura Health has appointed Justin James as its new CEO, bringing a wealth of healthcare leadership and a proven track record in specialty therapies to accelerate the company’s transformation.

Fiducian Group Limited has responded to a sharp share price drop by denying any undisclosed information and downplaying the impact of new APRA licence conditions on its operations.